Sarcoma  >>  Immune Checkpoint Inhibitors 


12»
Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Trials
 08162432404856647280
            
            
             
Keytruda (pembrolizumab) / Merck (MSD)           
          
            
             
Opdivo (nivolumab) / BMS           
          
            
             
Yervoy (ipilimumab) / BMS           
          
            
             
Tecentriq (atezolizumab) / Roche           
          
            
             
AiRuiKa (camrelizumab) / HLB Bio Group           
          
            
             
Imfinzi (durvalumab) / AstraZeneca           
          
            
             
Bavencio (avelumab) / EMD Serono           
          
            
             
Tevimbra (tislelizumab-jsgr) / BeiGene           
          
            
             
Tyvyt (sintilimab) / Eli Lilly           
          
            
             
Imjudo (tremelimumab) / AstraZeneca, Pfizer           
          
            
             
Jemperli (dostarlimab-gxly) / GSK           
          
            
             
Loqtorzi (toripalimab-tpzi) / Shanghai Junshi Biosci, Coherus Biosci           
          
            
             
Libtayo (cemiplimab-rwlc) / Regeneron           
          
            
             
Kaitanni (cadonilimab) / Akesobio           
          
            
             
Enweida (envafolimab) / 3DMed, Tracon Pharma, Ascletis           
          
            
             
Zynyz (retifanlimab-dlwr) / Incyte           
          
            
             
bintrafusp alfa (M7824) / EMD Serono           
          
            
             
spartalizumab (PDR001) / Novartis           
          
            
             
Anniko (penpulimab) / Akesobio, Sino Biopharm           
          
            
             
balstilimab (AGEN2034) / Agenus           
          
            
             
socazolimab (STI-A1014) / Sorrento           
          
            
             
Yutuo (zimberelimab) / Arcus Biosci, Gilead           
          
            
             
botensilimab (AGEN1181) / Agenus           
          
            
             
Omblastys (131I-omburtamab) / Y-mAbs Therap           
          
            
             
T3011 / ImmVira Pharma           
          
            
             
benmelstobart (APL-502) / Apollomics           
          
            
             
epacadostat (INCB024360) / Incyte           
          
            
             
ezabenlimab (BI 754091) / Boehringer Ingelheim           
          
            
             
indoximod (NLG8189) / Lumos Pharma           
          
            
             
izuralimab (XmAb23104) / Xencor           
          
            
             
relatlimab (BMS-986016) / BMS, Ono Pharma           
          
            
             
sasanlimab (PF-06801591) / Pfizer           
          
            
             
zalifrelimab (UGN-301) / UroGen           
          
            
             
Aibining (geptanolimab) / Apollomics           
          
            
             
CDX-1140 / Celldex           
          
            
             
DNX-2440 / DNAtrix           
          
            
             
GI-101 / GI Innovation           
          
            
             
GSK5764227 / GSK           
          
            
             
LAE005 / Laekna Therap           
          
            
             
MHB088C / Minghui Pharma           
          
            
             
MK-4830 / Merck (MSD)           
          
            
             
NY-ESO-1 TCR-T cell therapy / Gilead           
          
            
             
Puyouheng (pucotenlimab) / Taizhou Hanzhong Biopharma, Lepu Med           
          
            
             
VG161 / ViroGin Biotech           
          
            
             
ciforadenant (CPI-444) / Corvus Pharma           
          
            
             
enoblituzumab (MGA271) / MacroGenics           
          
            
             
etrumadenant (AB928) / Arcus Biosci, Gilead           
          
            
             
fianlimab (REGN3767) / Regeneron           
          
            
             
gotistobart (BNT316) / OncoC4, BioNTech           
          
            
             
ieramilimab (LAG525) / Novartis           
          
            
            


12»